LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 48

Search options

  1. Article ; Online: Timely Treatment Translates: A Vision for Eradicating HCV.

    Bositis, Christopher M / Tana, Michele M

    NAM perspectives

    2023  Volume 2023

    Language English
    Publishing date 2023-07-10
    Publishing country United States
    Document type Journal Article
    ISSN 2578-6865
    ISSN (online) 2578-6865
    DOI 10.31478/202307b
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Thinking Ahead: Advance Care Planning for Patients With Cirrhosis.

    Deng, Lisa X / Tana, Michele M / Lai, Jennifer C

    Clinical liver disease

    2021  Volume 19, Issue 1, Page(s) 7–11

    Language English
    Publishing date 2021-09-13
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2657644-2
    ISSN 2046-2484
    ISSN 2046-2484
    DOI 10.1002/cld.1157
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases.

    Lee, Brian T / Tana, Michele M / Kahn, Jeffrey A / Dara, Lily

    Hepatology (Baltimore, Md.)

    2021  Volume 74, Issue 5, Page(s) 2876–2887

    Abstract: Autoimmune liver diseases are attributed to a complex interplay of biologic, acquired, and environmental factors. Increased prevalence, later stage at presentation, worse response to standard therapy, and transplant-related disparities have all been ... ...

    Abstract Autoimmune liver diseases are attributed to a complex interplay of biologic, acquired, and environmental factors. Increased prevalence, later stage at presentation, worse response to standard therapy, and transplant-related disparities have all been reported in racial and ethnic minorities such as Black and Latinx patients with autoimmune liver diseases. While biology and inherited genetic predispositions may partly explain these disparities, definitive and universal genetic variations underlying these differences in outcomes have not been defined. Nonetheless, socioeconomic status, access to health care, environmental and societal factors, and implicit provider bias can all contribute to poor patient outcomes. There remains an unmet need to understand and mitigate the factors contributing to health inequity in autoimmune liver diseases. In this review, we summarize the data on racial and ethnic disparities in presentation, treatment response, and outcomes pertaining to autoimmune liver diseases in minority populations, on the premise that understanding disparities is the first step toward reaching health equity.
    MeSH term(s) Blacks/statistics & numerical data ; Cholangitis, Sclerosing/epidemiology ; Cholangitis, Sclerosing/immunology ; Cholangitis, Sclerosing/therapy ; Ethnic and Racial Minorities/statistics & numerical data ; Health Inequities ; Health Services Accessibility ; Health Services Needs and Demand ; Hepatitis, Autoimmune/epidemiology ; Hepatitis, Autoimmune/immunology ; Hepatitis, Autoimmune/therapy ; Hispanic or Latino/statistics & numerical data ; Humans ; Liver/immunology ; Social Determinants of Health/statistics & numerical data ; United States/epidemiology
    Language English
    Publishing date 2021-08-10
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.31985
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals.

    Yilma, Mignote / Kim, Nicole J / Shui, Amy M / Tana, Michele / Landis, Charles / Chen, Ariana / Bangaru, Saroja / Mehta, Neil / Zhou, Kali

    JAMA network open

    2023  Volume 6, Issue 6, Page(s) e2317549

    Abstract: Importance: A high proportion of underserved patients with cirrhosis receive care at safety-net hospitals (SNHs). While liver transplant (LT) can be a life-saving treatment for cirrhosis, data on referral patterns from SNHs to LT centers are lacking.: ...

    Abstract Importance: A high proportion of underserved patients with cirrhosis receive care at safety-net hospitals (SNHs). While liver transplant (LT) can be a life-saving treatment for cirrhosis, data on referral patterns from SNHs to LT centers are lacking.
    Objective: To identify factors associated with LT referral within the SNH context.
    Design, setting, and participants: This retrospective cohort study included 521 adult patients with cirrhosis and model for end-stage liver disease-sodium (MELD-Na) scores of 15 or greater. Participants received outpatient hepatology care at 3 SNHs between January 1, 2016, and December 31, 2017, with end of follow-up on May 1, 2022.
    Exposures: Patient demographic characteristics, socioeconomic status, and liver disease factors.
    Main outcomes and measures: Primary outcome was referral for LT. Descriptive statistics were used to describe patient characteristics. Multivariable logistic regression was performed to evaluate factors associated with LT referral. Multiple chained imputation was used to address missing values.
    Results: Of 521 patients, 365 (70.1%) were men, the median age was 60 (IQR, 52-66) years, most (311 [59.7%]) were Hispanic or Latinx, 338 (64.9%) had Medicaid insurance, and 427 (82.0%) had a history of alcohol use (127 [24.4%] current vs 300 [57.6%] prior). The most common liver disease etiology was alcohol associated liver disease (280 [53.7%]), followed by hepatitis C virus infection (141 [27.1%]). Median MELD-Na score was 19 (IQR, 16-22). One hundred forty-five patients (27.8%) were referred for LT. Of these, 51 (35.2%) were wait-listed, and 28 (19.3%) underwent LT. In a multivariable model, male sex (adjusted odds ratio [AOR], 0.50 [95% CI, 0.31-0.81]), Black race vs Hispanic or Latinx ethnicity (AOR, 0.19 [95% CI, 0.04-0.89]), uninsured status (AOR, 0.40 [95% CI, 0.18-0.89]), and hospital site (AOR, 0.40 [95% CI, 0.18-0.87]) were associated with lower odds of being referred. Reasons for not being referred (n = 376) included active alcohol use and/or limited sobriety (123 [32.7%]), insurance issues (80 [21.3%]), lack of social support (15 [4.0%]), undocumented status (7 [1.9%]), and unstable housing (6 [1.6%]).
    Conclusions: In this cohort study of SNHs, less than one-third of patients with cirrhosis and MELD-Na scores of 15 or greater were referred for LT. The identified sociodemographic factors negatively associated with LT referral highlight potential intervention targets and opportunities to standardize LT referral practices to increase access to life-saving transplant among underserved patients.
    MeSH term(s) Adult ; United States/epidemiology ; Humans ; Male ; Middle Aged ; Female ; Liver Transplantation ; Cohort Studies ; End Stage Liver Disease/epidemiology ; End Stage Liver Disease/surgery ; Retrospective Studies ; Safety-net Providers ; Severity of Illness Index ; Liver Cirrhosis/epidemiology ; Liver Cirrhosis/surgery ; Liver Diseases ; Referral and Consultation
    Language English
    Publishing date 2023-06-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 2574-3805
    ISSN (online) 2574-3805
    DOI 10.1001/jamanetworkopen.2023.17549
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?

    Tana, Michele M / Muir, Andrew J

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2017  Volume 16, Issue 1, Page(s) 16–18

    MeSH term(s) Blood Chemical Analysis/methods ; Diagnostic Tests, Routine/methods ; Histocytochemistry/methods ; Humans ; Liver Cirrhosis/diagnosis ; Optical Imaging/methods ; Severity of Illness Index
    Language English
    Publishing date 2017-07-08
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2017.06.050
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Outcomes of pregnancy in autoimmune hepatitis: A population-based study.

    Wang, Connie W / Grab, Joshua / Tana, Michele M / Irani, Roxanna A / Sarkar, Monika

    Hepatology (Baltimore, Md.)

    2021  Volume 75, Issue 1, Page(s) 5–12

    Abstract: Background and aims: Autoimmune hepatitis (AIH) disproportionately affects young women, which may have implications in pregnancy. However, data on pregnancy outcomes in women with AIH are limited.: Approach and results: Using weighted discharge data ... ...

    Abstract Background and aims: Autoimmune hepatitis (AIH) disproportionately affects young women, which may have implications in pregnancy. However, data on pregnancy outcomes in women with AIH are limited.
    Approach and results: Using weighted discharge data from the United States National Inpatient Sample from 2012 to 2016, we evaluated pregnancies after 20 weeks gestation and compared outcomes in AIH to other chronic liver diseases (CLD) or no CLD in pregnancy. The association of AIH with maternal and perinatal outcomes was assessed by logistic regression. Among 18,595,345 pregnancies, 935 (<0.001%) had AIH (60 with cirrhosis) and 120,100 (0.006%) had other CLD (845 with cirrhosis). Temporal trends in pregnancies with AIH remained stable from 2008 to 2016 with 1.4-6.8/100,000 pregnancies per year (p = 0.25). On adjusted analysis, the odds of gestational diabetes (GDM) and hypertensive complications (pre-eclampsia, eclampsia, or hemolysis, elevated liver enzymes, low platelets) were significantly higher in AIH compared to other CLD (GDM: OR 2.2, 95% CI: 1.5-3.9, p < 0.001; hypertensive complications: OR: 1.8, 95% CI: 1.0-3.2, p = 0.05) and also compared to no CLD in pregnancy (GDM: OR: 2.4, 95% CI: 1.6-3.6, p < 0.001; hypertensive complications: OR: 2.4, 95% CI: 1.3-4.1, p = 0.003). AIH was also associated with preterm births when compared with women without CLD (OR: 2.0, 95% CI: 1.2-3.5, p = 0.01). AIH was not associated with postpartum hemorrhage, maternal, or perinatal death.
    Conclusions: Rates of pregnancy in women with AIH have remained stable in recent years, although AIH is associated with notable maternal and perinatal risks, such as GDM, hypertensive complications, and preterm birth. Whether these risks are influenced by steroid use and/or AIH disease activity warrants evaluation. These data support a low risk of postpartum hemorrhage and favorable survival of mothers and infants.
    MeSH term(s) Adult ; Diabetes, Gestational/epidemiology ; Diabetes, Gestational/immunology ; Female ; Hepatitis, Autoimmune/complications ; Hepatitis, Autoimmune/immunology ; Humans ; Infant, Newborn ; Pre-Eclampsia/epidemiology ; Pre-Eclampsia/immunology ; Pregnancy ; Premature Birth/epidemiology ; Premature Birth/immunology ; Retrospective Studies ; United States/epidemiology
    Language English
    Publishing date 2021-12-05
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.32132
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease.

    Feuille, Colin / Kari, Swathi / Patel, Roshan / Oberoi, Rohan / Liu, Jonathan / Ohliger, Michael / Khalili, Mandana / Tana, Michele

    Scientific reports

    2024  Volume 14, Issue 1, Page(s) 1765

    Abstract: We aimed to characterize scenarios where magnetic resonance elastography (MRE) of the liver was ordered and its impact on clinical course and management. 96 consecutive MRE examinations and subsequent encounters over 14 months were reviewed. Indication ... ...

    Abstract We aimed to characterize scenarios where magnetic resonance elastography (MRE) of the liver was ordered and its impact on clinical course and management. 96 consecutive MRE examinations and subsequent encounters over 14 months were reviewed. Indication for MRE of the liver and subsequent management were abstracted from the medical record. In all cases, non-invasive assessment of liver fibrosis was the primary indication and at least one additional rationale was noted. There was a significant decrease in recommendations to undergo liver biopsy after MRE. Additionally, a greater percentage of those recommended to undergo biopsy completed the procedure after discussion of the results. Given the significant cost and rare but serious risks of liver biopsy, MRE of the liver provides an attractive, safer alternative that may have a comparable impact on management, or select cases where biopsy is essential to guide management. We demonstrate the versatility of MRE in real-world hepatology practice, including its utility as a non-invasive surrogate for liver biopsy.
    MeSH term(s) Humans ; Elasticity Imaging Techniques/methods ; Magnetic Resonance Imaging/methods ; Liver/diagnostic imaging ; Liver/pathology ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/pathology ; Disease Progression
    Language English
    Publishing date 2024-01-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-024-51295-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Barriers to liver transplant referral in safety net settings: A national provider survey.

    Hundt, Melanie / Chen, Ariana / Donovan, John / Kim, Nicole / Yilma, Mignote / Tana, Michele / Mehta, Neil / Zhou, Kali

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

    2024  

    Abstract: Background and aims: Safety net systems care for patients with a high burden of liver disease, yet experience many barriers to liver transplant (LT) referral. This study aimed to assess safety net providers' perspectives on barriers to LT referrals in ... ...

    Abstract Background and aims: Safety net systems care for patients with a high burden of liver disease, yet experience many barriers to liver transplant (LT) referral. This study aimed to assess safety net providers' perspectives on barriers to LT referrals in the United States (US).
    Methods: We conducted a nationwide anonymous online survey of self-identified safety net gastroenterologists and hepatologists from March through November 2022. This 27-item survey was disseminated via e-mail, society platforms, and social media. Survey sections included practice characteristics, transplant referral practices, perceived multilevel barriers to referral, potential solutions, and respondent characteristics.
    Results: 50 complete surveys were included in analysis. 60.0% of respondents self-identified as White, 54.0% male. 90.0% practiced in an urban setting, 82.0% in tertiary medical centers, and 16.0% in community settings with all four US regions represented. Perceived patient-level barriers ranked as most significant, followed by practice-level, then provider-level barriers. Patient-level barriers such as lack of insurance (72.0%), finances (66.0%), social support (66.0%), and stable housing/transportation (64.0%) were ranked as significant barriers to referral, while medical mistrust and lack of interest were not. Limited access to financial services (36.0%) and addiction/mental health resources (34.0%) were considered important practice-level barriers. Few reported existing access to patient navigators (12.0%), and patient navigation was ranked as most likely to improve referral practices, followed by an expedited/expanded pathway for insurance coverage for LT.
    Conclusion: In this national survey, safety net providers reported highest barriers to LT referral at the patient- and practice-level. These data can inform development of multilevel interventions in safety net settings to enhance equity in LT access for vulnerable patients.
    Language English
    Publishing date 2024-05-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2006866-9
    ISSN 1527-6473 ; 1527-6465
    ISSN (online) 1527-6473
    ISSN 1527-6465
    DOI 10.1097/LVT.0000000000000384
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Hepatitis B virus treatment: Management of antiviral drug resistance.

    Tana, Michele M / Ghany, Marc G

    Clinical liver disease

    2013  Volume 2, Issue 1, Page(s) 24–28

    Language English
    Publishing date 2013-03-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2657644-2
    ISSN 2046-2484
    ISSN 2046-2484
    DOI 10.1002/cld.162
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Obesity and metabolic outcomes in a safety-net health system.

    Huynh, Michael P / Bradshaw, Patrick T / Tana, Michele M / Rachocki, Carly / Somsouk, Ma

    Biodemography and social biology

    2020  Volume 65, Issue 3, Page(s) 257–267

    Abstract: In the United States, obesity has increased in prevalence over time and is strongly associated with subsequent outcomes such as diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). It is unclear, however, as to how the magnitude of NAFLD ... ...

    Abstract In the United States, obesity has increased in prevalence over time and is strongly associated with subsequent outcomes such as diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). It is unclear, however, as to how the magnitude of NAFLD risk from obesity and DM is increased in safety-net health system settings. Among the San Francisco Health Network (SFHN) patients (N = 47,211), we examined the association between Body Mass Index (BMI) and elevated liver enzyme levels, including interaction by DM status. Our findings revealed that 32.2 percent of SFHN patients were obese, and Pacific Islanders in the safety-net had the highest rates of obesity compared to other racial groups, even after using higher race-specific BMI cutoffs. In SFHN, obesity was associated with elevated liver enzymes, with the relationship stronger among those without DM. Our findings highlight how obesity is a stronger factor of NAFLD in the absence of DM, suggesting that practitioners consider screening for NAFLD among safety-net patients with obesity even if DM has not developed. These results highlight the importance of directing efforts to reduce obesity in safety-net health systems and encourage researchers to further examine effect modification between health outcomes in such populations.
    MeSH term(s) Adolescent ; Adult ; Aged ; Body Mass Index ; California/epidemiology ; Comorbidity ; Diabetes Mellitus/epidemiology ; Diabetes Mellitus/etiology ; Electronic Health Records/statistics & numerical data ; Female ; Hepatic Insufficiency/epidemiology ; Hepatic Insufficiency/etiology ; Humans ; Logistic Models ; Male ; Middle Aged ; Obesity/epidemiology ; Obesity/therapy ; Prevalence ; Risk Factors ; Safety-net Providers/methods ; Safety-net Providers/organization & administration ; Safety-net Providers/statistics & numerical data
    Language English
    Publishing date 2020-07-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2482287-5
    ISSN 1948-5573 ; 0037-766X ; 1948-5565
    ISSN (online) 1948-5573
    ISSN 0037-766X ; 1948-5565
    DOI 10.1080/19485565.2020.1765732
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top